{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T13:59:20Z","timestamp":1762783160933,"version":"3.33.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:00:00Z","timestamp":1725321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","redjournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ijrobp.2024.08.038","type":"journal-article","created":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T01:00:08Z","timestamp":1725152408000},"page":"547-557","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Planning Benchmark Study for Stereotactic Body Radiation Therapy of Pancreas Carcinomas With Simultaneously Integrated Boost and Protection: Results of the DEGRO\/DGMP Working Group on Stereotactic Radiation Therapy and Radiosurgery"],"prefix":"10.1016","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8879-2350","authenticated-orcid":false,"given":"Christos","family":"Moustakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Blanck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"Grohmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Albers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Bartels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bastian","family":"Bathen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppina Rita","family":"Borz\u00ec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Broggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Bruschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelina","family":"Casale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Delana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Doolan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Ebrahimi Tazehmahalleh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Fabiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Daniela","family":"Falco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman","family":"Fehr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Friedlein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Gutser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul Malek","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Hancock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janett","family":"K\u00f6hn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Kornhuber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Krieger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrike","family":"Lambrecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Lappi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenia","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalena","family":"Mirus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Muedder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandija","family":"Plaude","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"Polvika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Ravaglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Righetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Rinaldin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Schachner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Scaggion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Schilling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Szeverinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Villaggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"Walke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lotte","family":"Wilke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nils H.","family":"Nicolay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans Theodor","family":"Eich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Gkika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6780-2820","authenticated-orcid":false,"given":"Thomas B.","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2024.08.038_bib0001","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41575-021-00457-x","article-title":"Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors","volume":"18","author":"Klein","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ijrobp.2024.08.038_bib0002","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","article-title":"Pancreatic cancer","volume":"395","author":"Mizrahi","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2024.08.038_bib0003","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00066-020-01666-0","article-title":"FAK inhibition radiosensitizes pancreatic ductal adenocarcinoma cells in vitro","volume":"197","author":"Mohamed","year":"2021","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2024.08.038_bib0004","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1001\/jama.2016.4324","article-title":"Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib: the LAP07 randomized clinical trial","volume":"315","author":"Hammel","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2024.08.038_bib0005","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00066-020-01680-2","article-title":"R0 resection following chemo (radio)therapy improves survival of primary inoperable pancreatic cancer patients. Interim results of the German randomized CONKO-007\u00b1 trial","volume":"197","author":"Fietkau","year":"2021","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2024.08.038_bib0006","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00066-020-01654-4","article-title":"Evaluation of response using FDG-PET\/CT and diffusion weighted MRI after radiochemotherapy of pancreatic cancer: a non-randomized, monocentric phase II clinical trial-PaCa-DD-041 (Eudra-CT 2009-011968-11)","volume":"197","author":"Zimmermann","year":"2021","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2024.08.038_bib0007","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00066-020-01603-1","article-title":"Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO\/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery","volume":"196","author":"Guckenberger","year":"2020","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2024.08.038_bib0008","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00066-016-1053-1","article-title":"Stereotactic body radiotherapy for renal cell cancer and pancreatic cancer\u202f: literature review and practice recommendations of the DEGRO Working Group on Stereotactic Radiotherapy","volume":"192","author":"Panje","year":"2016","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2024.08.038_bib0009","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1002\/cncr.30706","article-title":"Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation","volume":"123","author":"Zhong","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2024.08.038_bib0010","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.radonc.2020.11.006","article-title":"A phase II study of stereotactic radiotherapy after FOLFIRINOX for locally advanced pancreatic cancer (LAPC-1 trial): long-term outcome","volume":"155","author":"Teriaca","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.08.038_bib0011","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.radonc.2014.10.015","article-title":"SBRT in pancreatic cancer: what is the therapeutic window?","volume":"114","author":"Brunner","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.08.038_bib0012","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ijrobp.2020.11.017","article-title":"Maximizing tumor control and limiting complications with stereotactic body radiation therapy for pancreatic cancer","volume":"110","author":"Mahadevan","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.08.038_bib0013","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1001\/jamaoncol.2022.2319","article-title":"Efficacy of preoperative mFOLFIRINOX vs mFOLFIRINOX plus hypofractionated radiotherapy for borderline resectable adenocarcinoma of the pancreas: the A021501 phase 2 randomized clinical trial","volume":"8","author":"Katz","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2024.08.038_bib0014","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00066-020-01583-2","article-title":"Technological quality requirements for stereotactic radiotherapy: expert review group consensus from the DGMP Working Group for Physics and Technology in Stereotactic Radiotherapy","volume":"196","author":"Schmitt","year":"2020","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2024.08.038_bib0015","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s00066-023-02085-7","article-title":"Interobserver agreement on definition of the target volume in stereotactic radiotherapy for pancreatic adenocarcinoma using different imaging modalities","volume":"199","author":"Gkika","year":"2023","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2024.08.038_bib0016","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ijrobp.2019.10.041","article-title":"Dosimetric multicenter planning comparison studies for stereotactic body radiation therapy: methodology and future perspectives","volume":"106","author":"Giglioli","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.08.038_bib0017","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1007\/s00066-017-1151-8","article-title":"Planning benchmark study for SBRT of early stage NSCLC: results of the DEGRO Working Group Stereotactic Radiotherapy","volume":"193","author":"Moustakis","year":"2017","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2024.08.038_bib0018","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/s00066-021-01799-w","article-title":"Improving inter-institutional and inter-technology consistency of pulmonary SBRT by dose prescription to the mean ITV dose","volume":"197","author":"Wilke","year":"2021","journal-title":"Strahlther Onkol"},{"key":"10.1016\/j.ijrobp.2024.08.038_bib0019","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijrobp.2022.01.008","article-title":"Planning benchmark study for stereotactic body radiation therapy of liver metastases: results of the DEGRO\/DGMP Working Group on Stereotactic Radiation Therapy and Radiosurgery","volume":"113","author":"Moustakis","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.08.038_bib0020","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s00066-016-1057-x","article-title":"Simultaneous integrated protection: a new concept for high-precision radiation therapy","volume":"192","author":"Brunner","year":"2016","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2024.08.038_bib0021","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00066-017-1099-8","article-title":"Stereotactic body radiotherapy (SBRT) in recurrent or oligometastatic pancreatic cancer: a toxicity review of simultaneous integrated protection (SIP) versus conventional SBRT","volume":"193","author":"Gkika","year":"2017","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2024.08.038_bib0022","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/j.clon.2020.06.019","article-title":"Hypofractionated stereotactic body radiation therapy with simultaneous integrated boost and simultaneous integrated protection in pancreatic ductal adenocarcinoma","volume":"33","author":"Simoni","year":"2021","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijrobp.2024.08.038_bib0023","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejmp.2019.05.003","article-title":"Plan quality improvement by DVH sharing and planner's experience: results of a SBRT multicentric planning study on prostate","volume":"62","author":"Villaggi","year":"2019","journal-title":"Phys Med"},{"key":"10.1016\/j.ijrobp.2024.08.038_bib0024","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ijrobp.2019.12.003","article-title":"MRI-based upper abdominal organs-at-risk atlas for radiation oncology","volume":"106","author":"Lukovic","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.08.038_bib0025","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/cncr.29161","article-title":"Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma","volume":"121","author":"Herman","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2024.08.038_bib0026","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.radonc.2018.10.025","article-title":"Radiotherapy quality assurance of SBRT for patients with centrally located lung tumours within the multicentre phase II EORTC Lungtech trial: benchmark case results","volume":"132","author":"Lambrecht","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.08.038_bib0027","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1120\/jacmp.v12i2.3368","article-title":"Dose tolerance limits and dose volume histogram evaluation for stereotactic body radiotherapy","volume":"12","author":"Grimm","year":"2011","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.ijrobp.2024.08.038_bib0028","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijrobp.2021.09.027","article-title":"A story of hypofractionation and the table on the wall","volume":"112","author":"Timmerman","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.08.038_bib0029","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.clon.2022.02.010","article-title":"UK 2022 consensus on normal tissue dose-volume constraints for oligometastatic, primary lung and hepatocellular carcinoma stereotactic ablative radiotherapy","volume":"34","author":"Diez","year":"2022","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijrobp.2024.08.038_bib0030","first-page":"1","article-title":"ICRU report 91. Prescribing, recording, and reporting of stereotactic treatments with small photon beams","volume":"14","author":"Seuntjens","year":"2014","journal-title":"J ICRU"},{"key":"10.1016\/j.ijrobp.2024.08.038_bib0031","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/acm2.12401","article-title":"DVH Analytics: a DVH database for clinicians and researchers","volume":"19","author":"Cutright","year":"2018","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.ijrobp.2024.08.038_bib0032","doi-asserted-by":"crossref","first-page":"122","DOI":"10.14316\/pmp.2017.28.3.122","article-title":"Institutional applications of Eclipse scripting programming interface to clinical workflows in radiation oncology","volume":"28","author":"Kim","year":"2017","journal-title":"Prog Med Phys"},{"key":"10.1016\/j.ijrobp.2024.08.038_bib0033","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1120\/jacmp.v17i3.6151","article-title":"Inverse treatment planning for spinal robotic radiosurgery: an international multi-institutional benchmark trial","volume":"17","author":"Blanck","year":"2016","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.ijrobp.2024.08.038_bib0034","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.radonc.2020.09.033","article-title":"RAdiotherapy Treatment plannINg study Guidelines (RATING): a framework for setting up and reporting on scientific treatment planning studies","volume":"153","author":"R\u00f8nn Hansen","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.08.038_bib0035","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ijrobp.2022.06.062","article-title":"In regard to Moustakis et al","volume":"114","author":"Oskan","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.08.038_bib0036","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ijrobp.2022.06.061","article-title":"In reply to Oskan","volume":"114","author":"Moustakis","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.08.038_bib0037","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.radonc.2017.01.013","article-title":"Stereotactic body radiotherapy for oligo-metastatic liver disease - influence of pre-treatment chemotherapy and histology on local tumor control","volume":"123","author":"Klement","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.08.038_bib0038","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s12885-018-4191-2","article-title":"The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases","volume":"18","author":"Andratschke","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2024.08.038_bib0039","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ijrobp.2020.03.005","article-title":"Correlating dose variables with local tumor control in stereotactic body radiation therapy for early-stage non-small cell lung cancer: a modeling study on 1500 individual treatments","volume":"107","author":"Klement","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.08.038_bib0040","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00066-024-02254-2","article-title":"Dose prescription for stereotactic body radiotherapy: general and organ-specific consensus statement from the DEGRO\/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery","volume":"200","author":"Brunner","year":"2024","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2024.08.038_bib0041","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1040673","article-title":"Clinical outcomes after online adaptive MR-guided stereotactic body radiotherapy for pancreatic tumors on a 1.5 T MR-linac","volume":"13","author":"Eijkelenkamp","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2024.08.038_bib0042","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.radonc.2022.06.005","article-title":"Plan quality assessment in clinical practice: results of the 2020 ESTRO survey on plan complexity and robustness","volume":"173","author":"Kaplan","year":"2022","journal-title":"Radiother Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624033157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624033157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T23:17:57Z","timestamp":1736983077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301624033157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0360301624033157"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.08.038","relation":{},"ISSN":["0360-3016"],"issn-type":[{"type":"print","value":"0360-3016"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Planning Benchmark Study for Stereotactic Body Radiation Therapy of Pancreas Carcinomas With Simultaneously Integrated Boost and Protection: Results of the DEGRO\/DGMP Working Group on Stereotactic Radiation Therapy and Radiosurgery","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.08.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}